[SCHEDULE 13G/A] SeaStar Medical Holding Corporation SEC Filing
Three reporting persons 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) and Waqas Khatri 鈥� report beneficial ownership of 294,361 shares of SeaStar Medical Holding Corp common stock. The filing states these shares are issuable upon exercise of warrants and that the issuable shares are subject to a 9.99% beneficial ownership blocker. The calculation of the 2.56% holding uses 11,203,752 shares outstanding as the reference base.
This ownership is held through an investment vehicle managed by Ayrton Capital, with sole voting and dispositive power reported for each reporting person. The statement certifies the holdings were acquired and are held in the ordinary course of business.
Tre soggetti comunicanti 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) e Waqas Khatri 鈥� dichiarano la titolarit脿 beneficiaria di 294,361 azioni ordinarie di SeaStar Medical Holding Corp. Il deposito indica che queste azioni sono emettibili all'esercizio di warrant e che le azioni emettibili sono soggette a un limite di possesso pari al 9,99%. Il calcolo della partecipazione del 2,56% utilizza 11,203,752 azioni in circolazione come base di riferimento.
Questa partecipazione 猫 detenuta tramite un veicolo d'investimento gestito da Ayrton Capital, e a ciascun soggetto comunicante 猫 attribuito il potere esclusivo di voto e di disposizione. La dichiarazione certifica che le partecipazioni sono state acquisite e sono detenute nell'ordinario corso dell'attivit脿.
Tres personas informantes 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) y Waqas Khatri 鈥� informan de la titularidad beneficiaria de 294,361 acciones ordinarias de SeaStar Medical Holding Corp. La presentaci贸n indica que estas acciones son emitibles al ejercicio de warrants y que las acciones emitibles est谩n sujetas a un l铆mite de titularidad beneficiaria del 9,99%. El c谩lculo de la participaci贸n del 2,56% utiliza 11,203,752 acciones en circulaci贸n como base de referencia.
Esta participaci贸n se mantiene a trav茅s de un veh铆culo de inversi贸n gestionado por Ayrton Capital, y para cada persona informante se declara el poder exclusivo de voto y de disposici贸n. La declaraci贸n certifica que las participaciones se adquirieron y se mantienen en el curso ordinario del negocio.
靹� 氇呾潣 氤搓碃鞛� 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) 氚� Waqas Khatri 鈥� 臧� SeaStar Medical Holding Corp 氤错喌欤� 294,361欤检潣 鞁れ 靻岇湢甓岇潉 氤搓碃頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 鞚� 欤检嫕霌れ澊 鞗岆煱韸� 頄夓偓 鞁� 氚滍枆霅� 靾� 鞛堧姅 欤检嫕鞚措┌ 氚滍枆 臧�電ロ暅 欤检嫕鞚� 9.99%鞚� 鞁れ 靻岇湢 鞝滍暅鞚� 氚涬姅雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 2.56%鞚� 氤挫湢 牍勳湪 靷办稖鞐愲姅 11,203,752欤检潣 鞙犿喌 欤检嫕 靾橁皜 旮办鞙茧 靷毄霅橃棃鞀惦媹雼�.
鞚� 靻岇湢甓岇潃 Ayrton Capital鞚� 鞖挫毄頃橂姅 韴瀽 靾橂嫧鞚� 韱淀暣 氤挫湢霅橂┌, 臧� 氤搓碃鞛愲姅 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅橃棃鞀惦媹雼�. 靹彪獏靹滊姅 頃措嫻 氤挫湢臧� 鞓侅梾鞚� 韱奠儊鞝侅澑 瓿检爼鞐愳劀 旆摑霅橃柎 氤挫湢霅橁碃 鞛堨潓鞚� 歃濍獏頃╇媹雼�.
Trois personnes d茅clarante 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) et Waqas Khatri 鈥� d茅clarent la propri茅t茅 b茅n茅ficiaire de 294,361 actions ordinaires de SeaStar Medical Holding Corp. Le d茅p么t indique que ces actions sont susceptibles d'锚tre 茅mises 脿 l'exercice de warrants et que les actions susceptibles d'锚tre 茅mises sont soumises 脿 un plafond de participation b茅n茅ficiaire de 9,99%. Le calcul de la participation de 2,56% prend pour base 11,203,752 actions en circulation.
Cette participation est d茅tenue via un v茅hicule d'investissement g茅r茅 par Ayrton Capital, chaque d茅clarant disposant du pouvoir exclusif de vote et de disposition. La d茅claration certifie que les avoirs ont 茅t茅 acquis et sont d茅tenus dans le cours normal des affaires.
Drei meldende Personen 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) und Waqas Khatri 鈥� melden das wirtschaftliche Eigentum an 294,361 Stammaktien von SeaStar Medical Holding Corp. Die Einreichung gibt an, dass diese Aktien durch Aus眉bung von Warrants auszugebende Aktien sind und dass die auszugebenden Aktien einer 9,99%-Grenze f眉r das wirtschaftliche Eigentum unterliegen. F眉r die Berechnung der 2,56%-Beteiligung werden 11,203,752 ausstehende Aktien als Bezugsgr枚脽e verwendet.
Dieses Eigentum wird 眉ber ein von Ayrton Capital verwaltetes Investmentvehikel gehalten; den meldenden Personen werden jeweils die alleinigen Stimm- und Verf眉gungsbefugnisse zugewiesen. Die Erkl盲rung best盲tigt, dass die Best盲nde im ordentlichen Gesch盲ftsverlauf erworben wurden und gehalten werden.
- Holdings disclosed are below 5%, indicating no control intent under the filing rules
- Reported holdings were acquired and are held in the ordinary course of business, per the certification
- Shares are issuable on exercise of warrants, so they are not currently outstanding common stock and do not convey immediate voting rights
- Issuable shares are subject to a 9.99% beneficial ownership blocker, limiting the potential for a rapid increase in ownership
- Document contains a numeric inconsistency (one section lists the Fund with a differing share count), which may require clarification
Insights
TL;DR: A 2.56% warrant-backed stake reported; small, non-controlling position with blocker limiting rapid accumulation.
The reported 294,361 shares are not currently outstanding common stock but are issuable upon exercise of warrants, which reduces immediate voting influence. The 2.56% stake (based on 11,203,752 outstanding shares) is below the 5% reporting threshold for control and is unlikely to materially affect SeaStar's capital structure absent further exercises or purchases. The 9.99% blocker restricts conversion that could otherwise increase influence quickly. Holdings are held through a Cayman investment vehicle managed by Ayrton Capital, with sole voting and dispositive power attributed to the reporting parties.
TL;DR: Disclosure shows governance risk is limited; position is small and constrained by a beneficial ownership blocker.
The filing indicates sole voting and dispositive power over the warrants' issuable shares, but because the shares are contingent on exercise and capped by a 9.99% blocker, there is limited potential for immediate control actions. Reporting through an investment manager structure (Ayrton Capital managing the Fund) is standard and documented. Investors should note that the document lists consistent voting/dispositive power figures, though one section contains a differing numeric entry for the Fund; the overall governance implication remains that this is a minority, non-controlling disclosure.
Tre soggetti comunicanti 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) e Waqas Khatri 鈥� dichiarano la titolarit脿 beneficiaria di 294,361 azioni ordinarie di SeaStar Medical Holding Corp. Il deposito indica che queste azioni sono emettibili all'esercizio di warrant e che le azioni emettibili sono soggette a un limite di possesso pari al 9,99%. Il calcolo della partecipazione del 2,56% utilizza 11,203,752 azioni in circolazione come base di riferimento.
Questa partecipazione 猫 detenuta tramite un veicolo d'investimento gestito da Ayrton Capital, e a ciascun soggetto comunicante 猫 attribuito il potere esclusivo di voto e di disposizione. La dichiarazione certifica che le partecipazioni sono state acquisite e sono detenute nell'ordinario corso dell'attivit脿.
Tres personas informantes 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) y Waqas Khatri 鈥� informan de la titularidad beneficiaria de 294,361 acciones ordinarias de SeaStar Medical Holding Corp. La presentaci贸n indica que estas acciones son emitibles al ejercicio de warrants y que las acciones emitibles est谩n sujetas a un l铆mite de titularidad beneficiaria del 9,99%. El c谩lculo de la participaci贸n del 2,56% utiliza 11,203,752 acciones en circulaci贸n como base de referencia.
Esta participaci贸n se mantiene a trav茅s de un veh铆culo de inversi贸n gestionado por Ayrton Capital, y para cada persona informante se declara el poder exclusivo de voto y de disposici贸n. La declaraci贸n certifica que las participaciones se adquirieron y se mantienen en el curso ordinario del negocio.
靹� 氇呾潣 氤搓碃鞛� 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) 氚� Waqas Khatri 鈥� 臧� SeaStar Medical Holding Corp 氤错喌欤� 294,361欤检潣 鞁れ 靻岇湢甓岇潉 氤搓碃頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 鞚� 欤检嫕霌れ澊 鞗岆煱韸� 頄夓偓 鞁� 氚滍枆霅� 靾� 鞛堧姅 欤检嫕鞚措┌ 氚滍枆 臧�電ロ暅 欤检嫕鞚� 9.99%鞚� 鞁れ 靻岇湢 鞝滍暅鞚� 氚涬姅雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 2.56%鞚� 氤挫湢 牍勳湪 靷办稖鞐愲姅 11,203,752欤检潣 鞙犿喌 欤检嫕 靾橁皜 旮办鞙茧 靷毄霅橃棃鞀惦媹雼�.
鞚� 靻岇湢甓岇潃 Ayrton Capital鞚� 鞖挫毄頃橂姅 韴瀽 靾橂嫧鞚� 韱淀暣 氤挫湢霅橂┌, 臧� 氤搓碃鞛愲姅 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅橃棃鞀惦媹雼�. 靹彪獏靹滊姅 頃措嫻 氤挫湢臧� 鞓侅梾鞚� 韱奠儊鞝侅澑 瓿检爼鞐愳劀 旆摑霅橃柎 氤挫湢霅橁碃 鞛堨潓鞚� 歃濍獏頃╇媹雼�.
Trois personnes d茅clarante 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) et Waqas Khatri 鈥� d茅clarent la propri茅t茅 b茅n茅ficiaire de 294,361 actions ordinaires de SeaStar Medical Holding Corp. Le d茅p么t indique que ces actions sont susceptibles d'锚tre 茅mises 脿 l'exercice de warrants et que les actions susceptibles d'锚tre 茅mises sont soumises 脿 un plafond de participation b茅n茅ficiaire de 9,99%. Le calcul de la participation de 2,56% prend pour base 11,203,752 actions en circulation.
Cette participation est d茅tenue via un v茅hicule d'investissement g茅r茅 par Ayrton Capital, chaque d茅clarant disposant du pouvoir exclusif de vote et de disposition. La d茅claration certifie que les avoirs ont 茅t茅 acquis et sont d茅tenus dans le cours normal des affaires.
Drei meldende Personen 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) und Waqas Khatri 鈥� melden das wirtschaftliche Eigentum an 294,361 Stammaktien von SeaStar Medical Holding Corp. Die Einreichung gibt an, dass diese Aktien durch Aus眉bung von Warrants auszugebende Aktien sind und dass die auszugebenden Aktien einer 9,99%-Grenze f眉r das wirtschaftliche Eigentum unterliegen. F眉r die Berechnung der 2,56%-Beteiligung werden 11,203,752 ausstehende Aktien als Bezugsgr枚脽e verwendet.
Dieses Eigentum wird 眉ber ein von Ayrton Capital verwaltetes Investmentvehikel gehalten; den meldenden Personen werden jeweils die alleinigen Stimm- und Verf眉gungsbefugnisse zugewiesen. Die Erkl盲rung best盲tigt, dass die Best盲nde im ordentlichen Gesch盲ftsverlauf erworben wurden und gehalten werden.
FAQ
What stake in SeaStar Medical (ICU) do Ayrton Capital, Alto Opportunity and Waqas Khatri report?
Are the reported SeaStar shares currently outstanding or contingent?
Does the filing indicate voting or disposal control over the shares?
Is there any limit on how much the reporting persons can acquire?
Was the ownership acquired to influence control of SeaStar (ICU)?
